Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02889016 · ClinicalTrials.gov registry record
Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS
A clinical trial of Pediatric Acute-Onset Neuropsychiatric Syndrome and PANS, sponsored by Stanford University.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT02889016: Recruiting study of Pediatric Acute-Onset Neuropsychiatric Syndrome and PANS, sponsored by Stanford University.
NCT02889016 is a study of Pediatric Acute-Onset Neuropsychiatric Syndrome and PANS that is actively recruiting participants, run by Stanford University. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02889016, a study of Pediatric Acute-Onset Neuropsychiatric Syndrome and PANS, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is an investigation of the neurologic, immunologic, and rheumatologic markers of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a condition characterized by the abrupt, dramatic onset of obsessive compulsive disorder (OCD) and/or eating restriction accompanied by equally abrupt and severe co-morbid neuropsychiatric symptoms, which include anxiety, emotional lability, depression, irritability, aggression, oppositionality, deterioration in school performance, behavioral (developmental) regression, sensory amplification, movement abnormalities, sleep disturbance, and urinary frequency. PANS is thought to be caused by infection, inflammation, or alternate triggers that is associated with a brain response that leads to these symptoms. The purpose of this study is to examine specific neurologic, immunologic, rheumatologic, and genomic, components in children with the acute-onset of psychiatric symptoms. This research may begin to uncover a much larger story of autoimmune processes that are involved in psychiatric disorders of childhood. By better understanding the etiologic components of psychiatric phenomenon, future treatments may be better targeted to underlying causes.
Primary Outcome
The investigators will report results of altered cerebral blood flow from patients with PANS.
Conditions Studied
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2013-03 |
| Est. Completion | 2028-03 |
What NCT02889016 shows while recruiting
NCT02889016 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 4 conditions, with Pediatric Acute-Onset Neuropsychiatric Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT02889016 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02889016 about?
NCT02889016 is a clinical study titled "Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS". This study is an investigation of the neurologic, immunologic, and rheumatologic markers of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a condition characterized by the abrupt, dramatic onset of obsessive compulsive disorder (OCD) and/or eating restriction accompanied by equally ...
What is the current status of trial NCT02889016?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2013-03. Estimated completion is 2028-03.
What conditions does trial NCT02889016 study?
This clinical trial studies the following conditions: Pediatric Acute-Onset Neuropsychiatric Syndrome, PANS, PANDAS, Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections.
Who is sponsoring clinical trial NCT02889016?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02889016 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Acute-Onset Neuropsychiatric Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia